SHP2 is a target of the immunosuppressant tautomycetin

Chemistry and Biology

Volumn 18, Issue 1, 2011, Pages 101-110

  Liu, Sijiu ^a   Yu, Zhihong ^a   Yu, Xiao ^a   Huang, Sheng Xiong ^b   Luo, Yinggang ^b   Wu, Li ^a   Shen, Weihua ^a   Yang, Zhenyun ^a   Wang, Lina ^a   Gunawan, Andrea M ^a   Chan, Rebecca J ^a   Shen, Ben ^b   Zhang, Zhong Yin ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FURAN DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE SHP 2; PYRAN DERIVATIVE; SPIRO COMPOUND; TAUTOMYCETIN; TAUTOMYCIN; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME SPECIFICITY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; MONOCYTE; PHOSPHORYLATION; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITORS; FURANS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; LIPIDS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MONOCYTES; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PYRANS; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS; SUBSTRATE SPECIFICITY; TYROSINE;

EID: 79251557809     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2010.10.015     Document Type: Article

References (50)

1. Y.M. Agazie, and M.J. Hayman Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling Mol. Cell. Biol. 23 2003 7875 7886
2. A.J. Barr, E. Ugochukwu, W.H. Lee, O.N. King, P. Filippakopoulos, I. Alfano, P. Savitsky, N.A. Burgess-Brown, S. Müller, and S. Knapp Large-scale structural analysis of the classical human protein tyrosine phosphatome Cell 136 2009 352 363
3. B.E. Bierer, P.S. Mattila, R.F. Standaert, L.A. Herzenberg, S.J. Burakoff, G. Crabtree, and S.L. Schreiber Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin Proc. Natl. Acad. Sci. USA 87 1990 9231 9235
4. T. Brdicka, T.A. Kadlecek, J.P. Roose, A.W. Pastuszak, and A. Weiss Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases Mol. Cell. Biol. 25 2005 4924 4933
5. A.T. Brünger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures Nature 355 1992 472 475
6. A.T. Brünger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, and N.S. Pannu Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54 1998 905 921
7. G. Chan, D. Kalaitzidis, and B.G. Neel The tyrosine phosphatase Shp2 (PTPN11) in cancer Cancer Metastasis Rev. 27 2008 179 192
8. R.J. Chan, M.B. Leedy, V. Munugalavadla, C.S. Voorhorst, Y. Li, M. Yu, and R. Kapur Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor Blood 105 2005 3737 3742
9. X.C. Cheng, T. Kihara, H. Kusakabe, J. Magae, Y. Kobayashi, R.P. Fang, Z.F. Ni, Y.C. Shen, K. Ko, and I. Yamaguchi A new antibiotic, tautomycin J. Antibiot. (Tokyo) 40 1987 907 909
10. X.C. Cheng, T. Kihara, X. Ying, M. Uramoto, H. Osada, H. Kusakabe, B.N. Wang, Y. Kobayashi, K. Ko, and I. Yamaguchi A new antibiotic, tautomycetin J. Antibiot. (Tokyo) 42 1989 141 144
11. X.C. Cheng, M. Ubukata, and K. Isono The structure of tautomycetin, a dialkylmaleic anhydride antibiotic J. Antibiot. (Tokyo) 43 1990 890 896 (Pubitemid 20239830)
12. X.C. Cheng, M. Ubukata, and K. Isono The structure of tautomycin, a dialkylmaleic anhydride antibiotic J. Antibiot. (Tokyo) 43 1990 809 819 (Pubitemid 20239822)
13. J. Chung, C.J. Kuo, G.R. Crabtree, and J. Blennis Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases Cell 69 1992 1227 1236
14. P.D. Emanuel, L.J. Bates, R.P. Castleberry, R.J. Gualtieri, and K.S. Zuckerman Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors Blood 77 1991 925 929
15. W.M. Flanagan, B. Corthesy, R.J. Bram, and G.R. Crabtree Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A Nature 352 1991 803 807
16. D.A. Gerber, C.A. Bonham, and A.W. Thomson Immunosuppressive agents: recent developments in molecular action and clinical application Transplant. Proc. 30 1998 1573 1579
17. D.J. Han, Y.L. Jeong, Y.M. Wee, A.Y. Lee, H.K. Lee, J.C. Ha, S.K. Lee, and S.C. Kim Tautomycetin as a novel immunosuppressant in transplantation Transplant. Proc. 35 2003 547
18. H. Hanafusa, S. Torii, T. Yasunaga, K. Matsumoto, and E. Nishida Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty J. Biol. Chem. 279 2004 22992 22995
19. T. Hunter Signaling - 2000 and beyond Cell 100 2000 113 127
20. T.A. Jones, J.Y. Zou, S.W. Cowan, and G.J. Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these models Acta Crystallogr. A 47 1991 110 119
21. J. Ju, W. Li, Q. Yuan, N.R. Peters, F.M. Hoffmann, S.R. Rajski, H. Osada, and B. Shen Functional characterization of ttm unveils new tautomycin analogs and insights into tautomycin biosynthesis and activity Org. Lett. 11 2009 1639 1642
22. C.J. Kuo, J. Chung, D.F. Fiorentino, W.M. Flanagan, J. Blenis, and G.R. Crabtree Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase Nature 358 1992 70 73
23. R.A. Laskowski, M.W. MacArthur, S.G. Hutchinson, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Cryst. 26 1993 283 291
24. cip/WAF1 induction via the extracellular signal-regulated kinase pathway Mol. Cancer Ther. 5 2006 3222 3231
25. W. Li, J. Ju, S.R. Rajski, H. Osada, and B. Shen Characterization of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis J. Biol. Chem. 283 2008 28607 28617
26. W. Li, Y. Luo, J. Ju, S.R. Rajski, H. Osada, and B. Shen Characterization of the Tautomycetin biosynthetic gene cluster from Streptomyces griseochromogenes provides new insight into dialkylmaleic anhydride biosynthesis J. Nat. Prod. 72 2009 450 459
27. J. Liu, J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 1991 807 815
28. Y. Luo, W. Li, J. Ju, Q. Yuan, N.R. Peters, F.M. Hoffmann, S.X. Huang, T.S. Bugni, S. Rajski, and H. Osada Functional characterization of TtnD and TtnF, unveiling new insights into tautomycetin biosynthesis J. Am. Chem. Soc. 132 2010 6663 6671
29. W. Luo, A. Peterson, B.A. Garcia, G. Coombs, B. Kofahl, R. Heinrich, J. Shabanowitz, D.F. Hunt, H.J. Yost, and D.M. Virshup Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex EMBO J. 26 2007 1511 1521
30. C. MacKintosh, and S. Klumpp Tautomycin from the bacterium Streptomyces verticillatus: another potent and specific inhibitor of protein phosphatases 1 and 2A FEBS Lett. 277 1990 137 140
31. S. Mitsuhashi, N. Matsuura, M. Ubukata, H. Oikawa, H. Shima, and K. Kikuchi Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1 Biochem. Biophys. Res. Commun. 287 2001 328 331
32. S. Mitsuhashi, H. Shima, N. Tanuma, N. Matsuura, M. Takekawa, T. Urano, T. Kataoka, M. Ubukata, and K. Kikuchi Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo J. Biol. Chem. 278 2003 82 88
33. S. Mitsuhashi, H. Shima, Y. Li, N. Tanuma, T. Okamoto, K. Kikuchi, and M. Ubukata Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation Int. J. Oncol. 33 2008 1027 1035
34. V. Munugalavadla, E.C. Sims, J. Borneo, R.J. Chan, and R. Kapur Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis Blood 110 2007 1612 1620
35. J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallogr. A 50 1994 157 163
36. B.G. Neel, H. Gu, and L. Pao The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling Trends Biochem. Sci. 28 2003 284 293
37. T.V. Nguyen, Y. Ke, E.E. Zhang, and G.S. Feng Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals J. Immunol. 177 2006 5990 5996
38. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
39. J.H. Shim, H.K. Lee, E.J. Chang, W.J. Chae, J.H. Han, D.J. Han, T. Morio, J.J. Yang, A. Bothwell, and S.K. Lee Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction Proc. Natl. Acad. Sci. USA 99 2002 10617 10622
40. M. Tartaglia, and B.D. Gelb Noonan syndrome and related disorders: genetics and pathogenesis Annu. Rev. Genomics Hum. Genet. 6 2005 45 68
41. T. Tiganis, and A.M. Bennett Protein tyrosine phosphatase function: the substrate perspective Biochem. J. 402 2007 1 15
42. N.K. Tonks Protein tyrosine phosphatases: from genes, to function, to disease Nat. Rev. Mol. Cell Biol. 7 2006 833 846
43. J. Yang, Z. Cheng, T. Niu, X. Liang, Z.J. Zhao, and G.W. Zhou Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1 J. Biol. Chem. 275 2000 4066 4071
44. Z. Yang, Y. Li, F. Yin, and R.J. Chan Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival Exp. Hematol. 36 2008 1285 1296
45. Z. Yang, T. Kondo, C.S. Voorhorst, S.C. Nabinger, L. Ndong, F. Yin, E.M. Chan, M. Yu, O. Würstlin, and C.P. Kratz Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants Mol. Cell. Biol. 29 2009 4376 4393
46. Z.-Y. Zhang Protein tyrosine phosphatases: prospects for therapeutics Curr. Opin. Chem. Biol. 5 2001 416 423
47. Z.-Y. Zhang Mechanistic studies on protein tyrosine phosphatases Prog. Nucleic Acid Res. Mol. Biol. 73 2003 171 220
48. S. Zhang, and Z.-Y. Zhang PTP1B as a drug target: recent development in PTP1B inhibitor discovery Drug Discov. Today 12 2007 373 381
49. S.Q. Zhang, W. Yang, M.I. Kontaridis, T.G. Bivona, G. Wen, T. Araki, J. Luo, J.A. Thompson, B.L. Schraven, and M.R. Philips Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment Mol. Cell 13 2004 341 355
50. X. Zhang, Y. He, S. Liu, Z. Yu, Z.X. Jiang, Z. Yang, Y. Dong, S.C. Nabinger, L. Wu, and A.M. Gunawan Salicylic acid-based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) J. Med. Chem. 53 2010 2482 2493